Does VEMURAFENIB Cause Ejection fraction decreased? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Ejection fraction decreased have been filed in association with VEMURAFENIB (ZELBORAF). This represents 0.6% of all adverse event reports for VEMURAFENIB.
52
Reports of Ejection fraction decreased with VEMURAFENIB
0.6%
of all VEMURAFENIB reports
5
Deaths
20
Hospitalizations
How Dangerous Is Ejection fraction decreased From VEMURAFENIB?
Of the 52 reports, 5 (9.6%) resulted in death, 20 (38.5%) required hospitalization, and 2 (3.8%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEMURAFENIB. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does VEMURAFENIB Cause?
Rash (1,202)
Arthralgia (783)
Off label use (782)
Fatigue (773)
Diarrhoea (655)
Nausea (601)
Pyrexia (569)
Death (505)
Alopecia (445)
Decreased appetite (383)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which VEMURAFENIB Alternatives Have Lower Ejection fraction decreased Risk?
VEMURAFENIB vs VENETOCLAX
VEMURAFENIB vs VENLAFAXINE
VEMURAFENIB vs VENTAVIS
VEMURAFENIB vs VENTOLIN
VEMURAFENIB vs VENTOLIN HFA